Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Feb. 20, 2015, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $98.84 to $10,479,200.00.

Highlighted Stocks Traded by Insiders:

Solera Holdings (SLH) - FREE Research Report

Kingsbury Arthur F, who is Director at Solera Holdings, sold 5,000 shares at $54.85 on Feb. 20, 2015. Following this transaction, the Director owned 28,274 shares meaning that the stake was reduced by 15.03% with the 5,000-share transaction.

The shares most recently traded at $54.66, down $0.19, or 0.35% since the insider transaction. Historical insider transactions for Solera Holdings go as follows:

  • 4-Week # shares sold: 1,825
  • 12-Week # shares sold: 1,825
  • 24-Week # shares sold: 1,825

The average volume for Solera Holdings has been 588,000 shares per day over the past 30 days. Solera Holdings has a market cap of $3.7 billion and is part of the technology sector and computer software & services industry. Shares are up 8.03% year-to-date as of the close of trading on Friday.

Solera Holdings, Inc. provides software and services to insurance companies, collision repair facilities, independent assessors, automotive recyclers, auto dealers, and households. The stock currently has a dividend yield of 1.43%. The company has a P/E ratio of 83.8. Currently, there are 8 analysts who rate Solera Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SLH - FREE

TheStreet Quant Ratings rates Solera Holdings as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income and impressive record of earnings per share growth. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, weak operating cash flow and generally higher debt management risk. Get the full Solera Holdings Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Essent Group (ESNT) - FREE Research Report

Mcalee Lawrence E Jr, who is Senior Vice President and CFO at Essent Group, sold 2,000 shares at $24.10 on Feb. 20, 2015. Following this transaction, the Senior Vice President and CFO owned 296,483 shares meaning that the stake was reduced by 0.67% with the 2,000-share transaction.

Gibbons Mary Lourdes, who is SVP and Chief Legal Officer at Essent Group, sold 4,000 shares at $24.10 on Feb. 20, 2015. Following this transaction, the SVP and Chief Legal Officer owned 284,125 shares meaning that the stake was reduced by 1.39% with the 4,000-share transaction.

The shares most recently traded at $23.26, down $0.84, or 3.61% since the insider transaction.

The average volume for Essent Group has been 410,800 shares per day over the past 30 days. Essent Group has a market cap of $2.0 billion and is part of the financial sector and real estate industry. Shares are down 8.67% year-to-date as of the close of trading on Friday.

Essent Group Ltd., through its subsidiaries, operates as a mortgage insurance company in the United States. It offers private mortgage insurance, including primary and pool insurance products, as well as reinsurance products for mortgages secured by residential properties. The company has a P/E ratio of 22.9. Currently, there are 4 analysts who rate Essent Group a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ESNT - FREE

TheStreet Quant Ratings rates Essent Group as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. Get the full Essent Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Acadia Healthcare (ACHC) - FREE Research Report

Duckworth David M., who is Chief Financial Officer at Acadia Healthcare, sold 9,504 shares at $62.31 on Feb. 20, 2015. Following this transaction, the Chief Financial Officer owned 20,177 shares meaning that the stake was reduced by 32.02% with the 9,504-share transaction.

The shares most recently traded at $62.64, up $0.33, or 0.52% since the insider transaction. Historical insider transactions for Acadia Healthcare go as follows:

  • 4-Week # shares sold: 38,624
  • 12-Week # shares sold: 41,124
  • 24-Week # shares sold: 195,846

The average volume for Acadia Healthcare has been 329,700 shares per day over the past 30 days. Acadia Healthcare has a market cap of $3.8 billion and is part of the health care sector and health services industry. Shares are up 4.22% year-to-date as of the close of trading on Friday.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, and substance abuse facilities in the United States. The company has a P/E ratio of 41.7. Currently, there are 9 analysts who rate Acadia Healthcare a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ACHC - FREE

TheStreet Quant Ratings rates Acadia Healthcare as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Acadia Healthcare Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null